European biotech – surviving the storm
European biotech – surviving the storm
To endure a storm, a sailor must frequently tack and adjust the rigging and the analogy holds true for those at the helm of Europe�s biotechnology companies.
European biotech – surviving the storm
To endure a storm, a sailor must frequently tack and adjust the rigging and the analogy holds true for those at the helm of Europe�s biotechnology companies.
Pharma marketing’s changing skills set
As the pharmaceutical industry reacts to change there is a race to find high-calibre commercial executives, but what skills should these individuals possess?
Create Competition In Expanding Biotech Field
The biotech field is booming and managed care is scrambling to level the playing field by creating competition.
Bacteria Make More Electricity
Researchers from the University of Massachusetts at Amherst have identified a microorganism that is particularly good at converting sugars to electricity under natural conditions.
Geneticists hunt control patterns
The Human Epigenome Project will look for patterns in our ‘life code’ that are associated with gene regulation but are also implicated in causing disease.
Researchers at Epigenomics AG in Berlin and the Sanger Institute in Cambridge will take part in the five-year study.
Yali Friedman lives in Washington, DC and is author of Building Biotechnology and other books; founder of DrugPatentWatch; and chief editor of the Journal of Commercial Biotechnology.

Recent Comments